IQVIA
IQV
$235.00
Share price
0.56%
Change (1 day)
22.90%
Change (1 year)
IQVIA (IQV) - P/B ratio
P/B ratio as of May 2024 : 6.75
According to IQVIA's latest financial reports the company has a price-to-book ratio of 6.75.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
IQVIA - P/B ratio (from 2013 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 6.91 | 4.66% |
| 2022-12-31 | 6.60 | -26% |
| 2021-12-31 | 8.92 | 63.09% |
| 2020-12-31 | 5.47 | 15.3% |
| 2019-12-31 | 4.74 | 43.79% |
| 2018-12-31 | 3.30 | 33.58% |
| 2017-12-31 | 2.47 | 16.89% |
| 2016-12-31 | 2.11 | -108.66% |
| 2015-12-31 | -24.4 | 135.02% |
| 2014-12-31 | -10.4 | 15.32% |
| 2013-12-31 | -9.00 | |
| 2012-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | -6.34 | -194.00% | Bahamas |
 NRC Health
NRC | 15.5 | 130.10% | 🇺🇸 USA |